HomeGRCE • NASDAQ
Grace Therapeutics, Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.70M | 21.72% |
Net income | -4.16M | -73.78% |
Net profit margin | — | — |
Earnings per share | -0.51 | -81.00% |
EBITDA | -3.70M | -21.70% |
Effective tax rate | 12.71% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 11.06M | -55.98% |
Total assets | 61.22M | -19.64% |
Total liabilities | 9.09M | -21.03% |
Total equity | 52.14M | — |
Shares outstanding | 10.14M | — |
Price to book | 0.36 | — |
Return on assets | -14.63% | — |
Return on capital | -17.10% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -4.16M | -73.78% |
Cash from operations | -4.12M | -117.49% |
Cash from investing | 15.00K | 100.23% |
Cash from financing | — | — |
Net change in cash | -4.10M | 51.46% |
Free cash flow | -2.85M | -166.45% |
Previous close
$1.85
Day range
$1.82 - $2.05
Year range
$1.75 - $4.97
Market cap
19.67M USD
Avg Volume
32.27K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2002
Website
Employees
32
